Crossmark

Biodistribution of Cerivastatin, Repaglinide, Glyburide, Rosuvastatin, and Valsartan in Cynomolgus Monkeys and PBPK Analysis

Crossref DOI link: https://doi.org/10.1208/s12248-026-01237-8

Published Online: 2026-04-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Rui https://orcid.org/0000-0003-1825-2401
Jordan, Samantha https://orcid.org/0009-0000-1537-0205
Niosi, Mark https://orcid.org/0000-0003-4681-8855
Varma, Manthena V. S. https://orcid.org/0000-0002-9541-6329
Di, Li https://orcid.org/0000-0001-6117-9022
License Information

Text and Data Mining valid from 2026-04-08

Version of Record valid from 2026-04-08
More Information

Article History

Received: 2 December 2025

Accepted: 14 March 2026

First Online: 8 April 2026

Declarations

:

: All authors were employees of Pfizer, Inc. when the research was conducted.